Exelixis | EXEL - Employees Total Number


Exelixis reported 1.15K in Employees for its fiscal year ending in December of 2025.





Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
Agios Pharmaceuticals 486 103 Dec/2024
Akebia Therapeutics 167 37 Dec/2023
Amgen 28K 1.3K Dec/2024
AstraZeneca USD 89.9K 6.4K Dec/2023
Bayer 99.72K 1.65K Dec/2023
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Bristol-Myers Squibb 34.1K 0 Dec/2024
Cytokinetics 498 75 Dec/2024
Eisai 13.51K 2.44K Dec/2025
Eli Lilly 47K 4K Dec/2024
Esperion Therapeutics 240 41 Dec/2023
Exelixis 1.15K 163 Dec/2025
Genmab 2.68K 478 Dec/2024
Glaxosmithkline GBP 69.4K 20.7K Dec/2022
Incyte 2.62K 93 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
MacroGenics 339 18 Dec/2023
Merck 75K 3K Dec/2024
Moderna 5.8K 200 Dec/2024
Nektar Therapeutics 137 79 Dec/2023
Neurocrine Biosciences 1.8K 400 Dec/2024
Novartis USD 101.7K 2.62K Dec/2022
Pfizer 81K 7K Dec/2024
Puma Biotechnology 185 7 Dec/2023
Sanofi EUR 91.57K 3.87K Dec/2022
Takeda 47.46K 1.83K Dec/2025
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
Xencor 250 30 Dec/2024